Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC‐TFR Study

ABSTRACT Background While tyrosine kinase inhibitor (TKI) discontinuation is an established therapeutic goal, up to 60% of patients relapse after the first attempt. The feasibility of a second or third attempt at TKI discontinuation remains uncertain. Immune surveillance, particularly T‐cell and nat...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hiroshi Ureshino, Yukio Nakamura, Yemima Budirahardja, Iwao Nozawa, Keisuke Kidoguchi, Kazuharu Kamachi, Shinya Kimura
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-08-01
Series:	Cancer Medicine
Assuntos:	T‐cell immunology T‐cell receptor repertoire treatment‐free remission tyrosine kinase inhibitorchronic myeloid leukemia
Acceso en liña:	https://doi.org/10.1002/cam4.71142
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!